title: [Effects of preservatives in anti-glaucoma agents on the ocular surface].
abstract: In POAG patients with long-term treatment may have an ocular surface damage, that undesirable effect may lead to treatment discontinuation and reduced quality of their life. Preservative free formulations in patients who are sensitive to preservatives because of pre-existing or concomitant ocular could be the gold standard. This article presents the results of a study which used Timabak as replacement therapy of BAK containing T/molol maleate in POAG patients. The effects of this replacement were studied in a subjective plan also with objective methods of tear film and ocular surface study
authors.affiliation: U.M.F Carol Davila Bucuresti. potopvasile@yahoo.com
authors.forename: Vasile
authors.initials: V
authors.lastname: Potop
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003229:Conjunctival Diseases / Q000139:chemically induced; D003316:Corneal Diseases / Q000139:chemically induced; D005260:Female; D005901:Glaucoma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013666:Tears / Q000187:drug effects; D013999:Timolol / Q000009:adverse effects
chemical_list: D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical; D013999:Timolol